Results 181 to 190 of about 27,486 (234)

Heart Transplantation in Advanced Heart Failure Due to IgG4-Related Endomyocardial Fibrosis. [PDF]

JACC Case Rep
Burgos LM, Baro Vila RC, Vrancic JM, De Bortoli MA, Malano D, San Martino JA, Diez M.   +6 more
europepmc   +1 more source

Outcomes of Left Bundle Branch Area Pacing in Heart Failure Patients: A Systematic Review

Annals of Noninvasive Electrocardiology, Volume 31, Issue 2, March 2026.
LBBAP demonstrated significant improvements in cardiac function, with most studies reporting substantial increases in LVEF and reductions in QRSd. LBBAP is a promising alternative to conventional pacing strategies, offering superior electrical and mechanical synchronization, enhanced cardiac function, and better clinical outcomes.
Hina Ahmed Siddiqui, Mounika Kotte, Hilana Soliman Omar, Saad Manzoor, Zohaib Qasim, Fnu Abdullah, Sadia Siddique, Muhammad Bari Hassan, Ali Karim, Hansa Devi, Ekta Rani, Aniket Tara, Payal Bai, Sajid Ali, Hina Kumari, Sitara Jabeen, Vikram Kumar, Abida Perveen   +17 more
wiley   +1 more source

Familial restrictive cardiomyopathy: A novel troponin mutation

Indian Heart Journal, 2017
M. Subramanian, H. Ahamed, N. Mathew
doaj   +1 more source

Impact of Increasing Referral for ^99mTc-DPD Scintigraphy on Prognosis Across the Phenotypic Spectrum of Restrictive Cardiomyopathy. [PDF]

JACC Adv
Choy CH, Kwok CS, Wahid Y, Liu B, Turvey-Haigh L, Parker K, Cullis J, Parekh P, Hussain K, Akhtar A, Bradlow WM, Zaphiriou A, Baig S, Gillmore JD, Fontana M, Pinney J, Steeds RP, Moody WE.   +17 more
europepmc   +1 more source

Transcriptional and functional effects of mavacamten in multiple porcine and human models with hypertrophic cardiomyopathy

British Journal of Pharmacology, Volume 183, Issue 5, Page 1122-1139, March 2026.
Abstract Background and Purpose Mavacamten (MAVA) is a novel small molecule inhibitor of cardiac myosin, mitigating cardiomyocyte hypercontractility in patients with hypertrophic obstructive cardiomyopathy (HOCM). Despite its recent approval for clinical use, the transcriptional and functional impacts of MAVA remain not well understood.
Elisa Kiselev, Wilson Agyapong, Bjarne Jürgens, Elisa Mohr, Shambhabi Chatterjee, Hannah J. Hunkler, Jawad Salman, Giuseppe Cipriano, Marco Bentele, Junqing Liu, Jonas Specht, Kaja S. Menge, Florian J. G. Waleczek, Jonas A. Haas, Anselm A. Derda, Kristina Sonnenschein, Anika Gietz, Susanne Neumüller, Angelika Pfanne, Oliver Beetz, Michael Pflaum, Bettina Wiegmann, Yiangos Psaras, Christopher Toepfer, Robert Zweigerdt, Ante Radocaj, Theresia Kraft, Andre Zeug, Evgeni Ponimaskin, Wilhelm Korte, Alexander Horke, Arjang Ruhparwar, Maximilian Fuchs, Ke Xiao, Christian Bär, Natalie Weber, Thomas Thum   +36 more
wiley   +1 more source

Unmasking the Apex: Multimodality Imaging for the Evaluation of Left Ventricular Apical Obliteration. [PDF]

Diagnostics (Basel)
Dentamaro I, Dicorato MM, Basile P, Carella MC, Mangini F, Musci R, Ruggieri R, Urgesi E, Piscitelli L, Dentamaro S, Pontone G, Forleo C, Ciccone MM, Guaricci AI.   +13 more
europepmc   +1 more source

Genetic and Clinical Spectrum of Hereditary Transthyretin Amyloidosis in Brazil

Journal of the Peripheral Nervous System, Volume 31, Issue 1, March 2026.
ABSTRACT Background Transthyretin hereditary amyloidosis (ATTRv) clinical variability has been widely reported, not only across countries and variants but also among families and distinct regions within a single nation. One of the principal challenges in disease management is the accurate determination of age of onset (AOO), which is heterogeneous and ...
Gustavo Maximiano‐Alves, Carolina Lavigne‐Moreira, Marcus Vinicius Simões, Adilson Junior Pinto Galvão, Flavio Henrique Valicelli, Fernando Saraiva Coneglian, Elisa Vegezzi, Pedro Manoel Marques Garibaldi, Pedro José Tomaselli, Andrea Cortese, Wilson Marques Jr   +10 more
wiley   +1 more source

Loss or Gain: Myosin Heavy Chain Truncations in Hypertrophic Cardiomyopathy. [PDF]

J Am Heart Assoc
Pal S, Becker JR.
europepmc   +1 more source

Development and Psychometric Validation of the Spanish Version of the Experience of Living With Chronic Heart Failure—University of Navarra Scale

Nursing &Health Sciences, Volume 28, Issue 1, March 2026.
ABSTRACT Living with chronic heart failure (CHF) implies physical consequences but also alterations in personal identity, family and social roles, and spiritual needs. No patient‐reported outcome measures have been identified to know the meaning of living with CHF for the person.
Maddi Olano‐Lizarraga, Maribel Saracíbar‐Razquin, Amparo Zaragoza‐Salcedo, José Luis Cobo‐Sanchez, Santiago Pérez‐García, Aurora Simón‐Ricart, Pilar Ara‐Lucea, Leticia Jimeno‐San Martín, Montserrat Ducay‐Eguillor, Noelia De La Torre‐Lomas, Jesica Pérez‐Herreros, Nieves Moro‐Tejedor, Luis Guerra‐Sánchez, Laura Cambra‐Vidart, Silvia Salinas‐Urra, Carmen Rodriguez‐Blazquez, Maria João Forjaz, Alba Ayala, Jesús Martín‐Martín   +18 more
wiley   +1 more source

Clinical-genetic profiles and risk prediction model in childhood restrictive cardiomyopathy: a national cohort study of China. [PDF]

BMC Med
Chen H, Wang S, Quan J, Ding W, Liu C, Peng H, Wang J, Xiao Y, Li Z, Wang H, Gao L, Shi L, Li Y, Yang S, Zhang L, Huang Y, Liang P, Guo Q, Li J, Shan G, Zhang H, Liu X, Zhang H, Li W, Zhang B, Zhang C, Tong S, Chan W, Wang R, Zhang H, Han L, Lv T, Fu L.   +32 more
europepmc   +1 more source